Internal Medicine News - Flecainide acetate tablets
May 1, 2003 -- Flecainide acetate tablets are approved for the prevention of paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter,...
Journal of AOAC International - Simultaneous separation of 14 antiarrhythmic drugs and determination of mexiletine and flecainide by capillary zone electrophoresis
July 1, 2007 -- A method using capillary zone electrophoresis was developed for the simultaneous separation of 14 antiarrhythmic drugs belonging to various classes....
JCN Newswires - Eisai's Tambocor® Received Approval for Paroxysmal Atrial Fibrillation/Flutter
June 26, 2007 -- Tokyo, Japan, June 26, 2007 - (JCN Newswire) - Eisai Co., Ltd. announced today that an additional indication for Tambocor(R) Tablets 50 mg /100 mg...
Chain Drug Review - Par shipments
July 22, 2002 -- Par Pharmaceutical Inc. has begun shipping flecainide acetate (3M Pharmaceuticals' Tambocor). Par has been given 180 days of generic exclusivity for...
Chain Drug Review - Par launch
June 10, 2002 -- Par Pharmaceutical Inc. is launching flecainide acetate, an antiarrhythmic medication. With annual sales of about $110 million, 3M Pharmaceuticals...
Business Wire - Mylan Signs Licensing Agreement With 3M Pharmaceuticals
June 7, 2002 -- Business Editors PITTSBURGH--(BUSINESS WIRE)--June 7, 2002 Mylan Laboratories Inc. (NYSE: MYL) announced today that it has reached an agreement...
Drug Store News - Generic Tambocor receives FDA's OK - Food and Drug Administration approves generic anti-arrhythmia drug - Brief Article
September 10, 2001 -- Pharmaceutical Resources announced final FDA approval for flecainide acetate, the generic form of Tambocor. Alphapharm, a subsidiary of Merck KGaA,...
Drug Store News - Generic Tambocor gets approval - Brief Article
August 20, 2001 -- Pharmaceutical Resources received FDA approval for flecainide acetate, the generic form of Tambocor. Alphapharm, a subsidiary of Merck KGaA, filed an...
Medical Marketing and Media - Tambocor promo faulted by FDA
February 1, 2000 -- The FDA's Division of Drug Marketing, Advertising, and Communications complained in a recent letter that 3M Pharmaceuticals had included...
Warning Letter Bulletin - 3M Pharmaceuticals, St. Paul, MN
January 17, 2000 -- 3M Pharmaceuticals, St. Paul, MN, Nov. 1, 1999 (DDMAC). FDA stated that 3M's reprint carriers comparing its Tambocor (flecainide acetate) tablets...
